Human papillomavirus type 18 upstream regulatory region DNA (HPV18 URR)

The Human papillomavirus type 18 upstream regulatory region (HPV18 URR), also known as the long control region (LCR), is a critical non-coding segment of the viral genome that acts as the central control hub for viral gene expression and replication (Bernard, 2005, Journal of Clinical Virology). It contains the origin of replication and the p105 promoter, which drives the transcription of the E6 and E7 oncogenes (Kennedy et al., 2014, Journal of Virology). These oncogenes are essential for the maintenance of the malignant phenotype in HPV-associated cancers by inactivating host tumor suppressor proteins p53 and pRb (Desaintes & Demeret, 1996, Seminars in Cancer Biology). The URR is characterized by numerous binding sites for both viral (E2) and cellular transcription factors such as AP-1, Sp1, and NF-1, making it a prime target for therapeutic silencing (Edwards et al., 2011, Antiviral Research). Therapeutic strategies targeting this DNA region include the use of sequence-specific pyrrole-imidazole polyamides to competitively inhibit transcription factor binding and CRISPR/Cas9 systems designed to disrupt the URR sequence (Kennedy et al., 2014; Edwards et al., 2011). Successfully targeting the HPV18 URR can lead to the downregulation of viral oncoproteins, induction of apoptosis in cancerous cells, and potential clearance of persistent high-risk infections.

Other names

HPV18 Long Control RegionHPV18 LCRHPV18 non-coding regionHPV18 NCRHPV18 p105 promoter region

Inhibition of viral transcription by competitively blocking transcription factor binding sites or direct DNA cleavage to disrupt the expression of viral oncogenes.